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Background: For a good probiotic candidate, the abilities to adhere to intestinal epithelium and to fortify barrier
function are considered to be crucial for colonization and functionality of the strain. The strain Lactobacillus acidophilus
LAB20 was isolated from the jejunum of a healthy dog, where it was found to be the most pre-dominant lactobacilli.
In this study, the adhesion ability of LAB20 to intestinal epithelial cell (IECs) lines, IECs isolated from canine intestinal
biopsies, and to canine, porcine and human intestinal mucus was investigated. Further, we studied the ability of LAB20
to fortify the epithelial cell monolayer and to reduce LPS-induced interleukin (IL-8) release from enterocytes.
Results: We found that LAB20 presented higher adhesion to canine colonic mucus as compared to mucus isolated
from porcine colon. LAB20 showed adhesion to HT-29 and Caco-2 cell lines, and importantly also to canine IECs
isolated from canine intestinal biopsies. In addition, LAB20 increased the transepithelial electrical resistance (TER) of
enterocyte monolayers and thus strengthened the intestinal barrier function. The strain showed also anti-inflammatory
capacity in being able to attenuate the LPS-induced IL-8 production of HT-29 cells.
Conclusion: In conclusion, canine indigenous strain LAB20 is a potential probiotic candidate for dogs adhering to the
host epithelium and showing intestinal barrier fortifying and anti-inflammatory effects.
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The mammalian gastrointestinal tract (GIT) is colonized
by a complex microbiota, which interacts with the host
mucosa and maintains mucosal homeostasis in healthy
individuals [1,2]. Studies on mice model have shown that
the initial development of immune system is profoundly
influenced by the colonization of gut microbiota [3]. The
deficiency of immune maturation and the development
of intolerance towards commensal bacteria may lead to
chronic inflammatory diseases later in life [1,3]. The
maintenance of intestinal immune and physiological
homeostasis in mammals is mediated by sophisticated
interaction between intestinal microbiota and the host
mucosa, which consists of the epithelial cell layer and* Correspondence: veera.kainulainen@helsinki.fi
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unless otherwise stated.underlying lamina propria. The epithelial cell layer is not
merely a physical barrier, but also responds to stimuli,
e.g. by secreting mucus and inducing innate and adaptive
immune responses [4,5]. Intestinal epithelial cells (IECs)
express several pattern recognition receptors (PRRs) and
can detect microorganism-associated molecular patterns
(MAMPs) and subsequently release effector cytokines.
Thus, IECs are important players in orchestrating toler-
ance or inflammatory responses against the resident
microbiota. Commensal microbes have often developed a
mutualistic relationship with the host and induce tolero-
genic or immunoregulatory responses in the host [4].
Adhesion is considered as a crucial step for intestinal
bacteria to colonize and further interact with the host
epithelium and immune system. Intestinal bacteria can
adhere to mucus, or bind to exposed IECs via their sur-
face structures [6-9]. Lactobacillus species can be found
along the mammalian GIT with various counts, typicallyntral. This is an Open Access article distributed under the terms of the Creative
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[10]. The majority of strains utilized as probiotics be-
long to the genus Lactobacillus and a number of strains
have been shown to adhere strongly to the epithelium
[11-15]. Probiotics have been shown to modulate im-
mune responses, being able to competitively exclude
pathogenic bacteria, and enhance epithelial barrier
functions [4]. Promising results have been obtained also
in alleviating gastrointestinal disorders [16].
In response to enteropathogen infection, the intestinal
epithelium releases proinflammatory molecules to re-
cruit immune cells and induce an acute inflammatory
response. Inflammation is an essential physiological re-
sponse to infection and tissue protection, but non-
regulated inflammatory responses can give rise to tissue
injury and chronic disease [1,16]. Interleukin-8 (IL-8) is
one of the key chemokines, which is responsible for the
initiation of inflammatory cascades and recruitment of
neutrophils into the mucosa [17]. It is considered, that
after the acute inflammation, commensal bacteria have a
key role in providing regulatory immune stimuli to ex-
tinguish the inflammation back to basal level [1]. Also
probiotics have been demonstrated to suppress mucosal
inflammation and restore cytokine balance towards an
anti-inflammatory state [18-22].
Lactobacillus acidophilus strain LAB20 was isolated
from canine small intestine, where it was found to be
among predominant jejunal lactobacilli [23]. Further, ad-
ministered LAB20 could persist in the dog gut for more
than six weeks post-administration [24], which is a re-
markably long period for a probiotic strain. Typically,
probiotics are cleared from the majority of patients
within weeks after the administration is terminated
[25,26]. In the present study, we investigated the inter-
action of LAB20 with the host epithelium. We studiedFigure 1 Adhesion of L. acidophilus LAB20 to mucus. Adhesion (%) of 3
ileum, cecum, and colon (A) and to colonic mucus from different hosts (B) w
included for comparison. Results are the means ± standard deviations of five tit’s adhesion ability to canine mucus and IECs from dif-
ferent compartment of dog intestine and to IEC lines.
Further, we assessed the ability of LAB20 to attenuate
LPS-induced IL-8 release from IECs and to fortify epi-
thelial barrier function.
Results
Adhesion to mucus
First, we studied the ability of L. acidophilus LAB20 to
bind mucus isolated from duodenum, jejunum, ileum,
cecum and colon of canine intestine. We found that
LAB20 showed very similar adhesion efficiency to canine
mucus despite the mucus type i.e. from which intestinal
compartments the mucus was isolated from (Figure 1A).
Next, the capacity of LAB20 to adhere canine, human
and porcine colonic mucus was compared. Human de-
rived strain Lactobacillus rhamnosus GG (LGG), which
has previously been shown to bind to human colonic
mucus [7,27] was included in the experiment for compari-
son. LAB20 presented statistically significantly higher ad-
hesion to canine colonic mucus (1.6%) compared to
adhesion to porcine (0.7%) mucus (p < 0.05, Figure 1B).
However, the binding of LAB20 to human (1.0%) mucus
was not significantly different from adhesion to canine
mucus. LGG adhered to human (3.8%) and porcine
(2.2%) mucus more efficiently than LAB20 (p < 0.05),
whereas LAB20 showed higher adhesion to canine
mucus (Figure 1B).
Adhesion to IECs
Next, we studied the adherence of LAB20 to the epithe-
lial cell lines of different ages. Caco-2 cells differentiate
in 14 days after confluence [28], and the adhesion was
examined with undifferentiated cells (3 days) in addition
to cells at two differentiation stages (8 and 21 days). ForH-labeled LAB20 to mucus isolated from canine duodenum, jejunum,
as measured. The human derived strain 3H-labeled L. rhamnosus GG was
echnical replicates (parallel wells) of the representative experiments.
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29 cell line. LAB20 adhered similarly to Caco-2 and HT-
29 cell lines and there was no statistically significant
difference in the adherence of LAB20 to IECs of differ-
ent ages except the adhesion to 3-days old Caco-2 cells
was significantly lower compared to 8-days old but not
to 21-days old Caco-2 cells (Figure 2). In order to exam-
ine the adhesion of LAB20 to canine IECs, FITC-labeled
LAB20 cells were visualized with epifluorescence mi-
croscopy. LAB20 adhered to canine IECs isolated from
various parts of the intestine (Figure 3). The adherence
to IECS isolated from cecum and colon seemed higher
than to IECs from duodenum, jejunum or ileum, but the
assay did not allow proper quantitative measurement
and therefore, this difference remains unconfirmed.Ability to attenuate LPS-induced IL-8 production of
enterocytes
In order to assess the potential anti-inflammatory prop-
erties of LAB20, we measured its ability to reduce the
LPS-induced release of IL-8 from the HT-29 cell line.
The attenuation effect on IL-8 production was evaluated
by incubating HT-29 monolayer with LPS (0.1 or 1 ng/ml)
after the cell line was first exposed to fresh and freeze-
dried LAB20 and sterile culture medium (Figure 4). Prior
co-incubation of HT-29 cells with fresh LAB20 decreased
significantly (P < 0.05) the LPS-stimulated IL-8 produc-
tion with both LPS concentrations. However, the freeze-
dried LAB20 did not show reduction of secreted IL-8 as
compared to the freshly cultured LAB20 cells. Taken to-
gether, the results showed that the decrease of IL-8 pro-
duction, obtained by incubation with LAB20, was
depended on the properties of active, living cells. LAB20
recovery from the freeze-dried stage takes more than 8Figure 2 Adhesion of LAB20 to epithelial cell lines. Adhesion (%)
of 3H-labeled L. acidophilus LAB30 to 3-, 8-, and 21-day-old Caco-2
and HT-29 cells was measured. The results of five technical replicates
(parallel wells) from the representative experiment are expressed as
means ± standard deviations. Significant reduction (p < 0.05) in adhesion
compared to different aged IECs is indicated with an asterix.
Figure 3 Adhesion of LAB20 to the canine IECs. Adherence of
FITC-labelled bacteria to canine IECs obtained from duodenum (A),
jejunum (B), ileum (C), cecum (D), and colon (E) sections is shown
in the left panel. The arrows indicate LAB20 cells adhered to IECs.
The nucleus of IECs were stained with DAPI and are shown in the
right column.hours and thus we presumed it to remain inactive during
the one hour incubation of attenuation experiment.
In order to disclose the molecular mechanisms behind
the anti-inflammatory action of LAB20 we constructed a
recombinant derivate strain, SAA658, to down-regulate
the transcription of the exopolysaccharide synthesis epsE
gene in LAB20 using antisense RNA strategy (Additional
file 1). This strategy was chosen because knock-out mu-
tants were not possible to construct due to the low
transformation frequency (approximately 10 transfor-
mants μg−1 DNA) of LAB20. Our preliminary results
Figure 4 The LPS-induced IL-8 production in HT-29 cells in
response to medium, LAB20 cells, and freeze-dried LAB20
(FD-LAB20). Data are expressed as means ± standard deviations of
three technical replicates from a representative experiment. Significant
difference (p < 0.05) in the IL-8 production as compared to the
medium control is indicated with an asterisk.
Figure 5 The effect of LAB20 on transepithelial resistance (TER)
of the Caco-2 cell line. TER values (Ω/cm2) are the means ± standard
deviations of three technical replicates from a representative
experiment. Significant differences (p < 0.05) in TER-values between
bacterium-treated and untreated Caco-2 cells are indicated with
an asterix.
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have a role in the immunomodulatory activity of LAB20
(Additional file 1). However, the detailed properties of
the derivate strain and the effector molecules of anti-
inflammatory action still need to be resolved.
Effects of LAB20 on epithelial barrier function
The effect of LAB20 on epithelial barrier function was
studied by measuring transepithelial electric resistance
(TER). Nonpathogenic Escherichia coli has been shown
to disrupt the Caco-2 monolayer [29] and we included
E. coli TOP10 in the experiment as a negative control.
The epithelial cells were incubated with LAB20, E. coli
or sterile culture medium for 72 hours and TER was
measured every 24 hours. TER of epithelial cells treated
with LAB20 was significantly higher as compared to cells
treated with culture medium (Figure 5). In contrast, E.
coli decreased TER significantly already within 24 hours.
Discussion
Host-microbial interactions in the GIT are important for
gut health, first by inducing the maturation of gut im-
mune system in early life, and later in maintaining im-
mune and physiological homeostasis of the mucosa
[2,30-32]. It is considered that for an effective inter-
action with the host mucosa, bacteria must adhere to in-
testinal mucus or IECs. Adherence of probiotic bacteria
to the intestinal epithelium is an important characteristic
as it also promotes persistence time and colonization.L. acidophilus LAB20 showed approximately 1.2-1.6%
adhesion to canine mucus isolated from different intes-
tinal compartments (Figure 1A) whereas the adhesion was
lower to human- or porcine-derived mucus (Figure 1B).
Instead, human-derived strain L. rhamnosus GG showed
overall the highest adhesion ability to human colonic
mucus. The results reinforce the suggestion that the
adhesion of bacteria toward mucus is strain-specific,
which may be due to the various bacterial surface struc-
tures associate with adhesion [7,11,27,33,34]. On the
other hand, strains may display some degree of host
specificity in the adhesion, although the strain origin is
not always reflected in host specificity in adhesion
[33,35].
The result showed that LAB20 could adhere to both
Caco-2 and HT-29 cell lines, which are commonly used
in vitro models to study microbe-IEC interactions [36].
Further, with access to canine IECs from different intes-
tinal compartments, we presented that LAB20 could ad-
here to canine IECs as well. Canine intestinal epithelial
cell lines are not commercially available and therefore,
we used IECs isolated from duodenum, jejunum, ileum,
cecum, and colon biopsies of healthy dogs. The gastro-
intestinal epithelium is covered with mucus, which
forms a thick, continuous layer in the large intestine.
However, in the small intestine, the mucus layer is thin-
ner and discontinuous, allowing direct contact between
epithelial cells and luminal bacteria. Also, under certain
conditions, the mucus barrier is reduced, and bacteria
can penetrate the layer and adhere to the underlying epi-
thelial cells [37]. The canine jejunal isolate, LAB20, was
previously found to persist in the gut of healthy dog for
over six weeks after cessation of administration [24].
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the effective adhesion to host IECs in the small intestine.
LAB20 was originally isolated from healthy canine je-
junum, which makes it intriguing to it’s potential immu-
nomodulatory effects. Canine primary colonic epithelial
cells isolated from normal dogs express TLR4 that can
be stimulated in response to LPS [38]. On the other
hand, increased expression of TLR4 has been linked to
inflammatory bowel disease (IBD) in dogs [39-41]. Fur-
ther, LPS-carrying Proteobacteria are increased in hu-
man IBD subjects [42], and this bacterial phylum and
LPS may play a role also in canine IBD. In this study, we
used LPS-induced inflammation in HT-29 cell line as a
model, because HT-29 cells express TLR4 that mediates
LPS stimulation in IECs [43]. We found that LAB20 is
able to attenuate LPS-induced release of IL-8 from HT-
29 cell line. Previously, it has been shown that the
stimulation of IECs with one MAMP can induce toler-
ance towards other MAMPs and modulate the inflam-
matory response of IECs [44]. This is a likely scenario
also in the case of the attenuation of LPS-induced IL-8
secretion by LAB20. The result indicates that LAB20
could balance the IL-8 expression of enterocytes in re-
sponse to apical stimulation by LPS from Gram-negative
bacteria in the intestine. Most of the LPS-carrying bac-
teria in the GIT are harmless commensals. However, if
the host responses to them are inappropriate or exagger-
ated, chronic inflammation (without infection) may en-
sue. There is growing evidence that aberrant innate
immune responses towards the gut microbiota play a
role in the pathogenesis of canine IBD [39,40]. Import-
antly, TLR4 expression is increased in dogs suffering
from chronic enteropathies including IBD [39-41]. Thus,
LAB20 seems to be able to induce in IECs tolerogenic
response towards LPS derived from the intestinal
microbiota.
Previously, bifidobacteria and Lactobacillus fermentum
have been demonstrated to inhibit LPS or Yersinia enter-
ocolitica –induced IL-8 production by IECs [45,46].
Moreover, several studies have shown that bifidobacteria
and lactobacilli can reduce the severity of inflammation
in vivo in rodent models and patients with IBD
[18,19,47]. Our preliminary results suggest that EPS of
LAB20 may have a role in the immunomodulatory activ-
ity of LAB20 (Additional file 1). Lactobacillus amylo-
vorus inhibits the TLR4 inflammatory signaling triggered
by enterotoxigenic E. coli and TLR2 is required for the
suppression of TLR4 signaling activation [48]. Further,
EPS of Lactobacillus delbrueckii have been shown to at-
tenuate enterotoxigenic E. coli -induced inflammatory
response in porcine IECs and TLR2 plays a central role
in the immunomodulatory action [49]. Concerning
LAB20, further studies are needed to confirm the anti-
inflammatory properties in vivo in dogs.One of the proposed mechanisms of action of pro-
biotic LAB is the ability to strengthen the epithelial
barrier [50]. We measured Caco-2 cell monolayer’s re-
sistance, TER, as an indicator of GI-epithelial barrier
function. Co-culture of Caco-2 cells with LAB20 forti-
fied epithelial barrier, as demonstrated by the increase
in TER. The Caco-2 cell line is a well-characterized
model of the gut epithelium and is capable of differenti-
ation and polarization [51] and measuring TER of polar-
ized cell monolayers is commonly used as a screening
assay to test for probiotic effects [45,52-54]. As expected,
the non-pathogenic E. coli used in the experiment as a
control disrupted the barrier integrity [29,55]. Thus,
LAB20 can fortify intestinal barrier function by tighten-
ing the epithelial cell layer and inducing tolerance to-
wards LPS.
Conclusions
In conclusion, we demonstrated that canine derived
strain LAB20 has potential as a probiotic as it adheres
to mucus and IECs and interact with the host. Specific-
ally, it fortifies epithelial cell layer, and is able to elicit
anti-inflammatory responses in enterocytes. The anti-
inflammatory property appeared to be associated with cell
viability and activity, but the precise mechanisms, espe-
cially the components responsible for anti-inflammatory
functions remain to be identified.
Methods
Microorganisms and growth condition
L. acidophilus LAB20 was previously isolated from ca-
nine jejunal chime [23]. It was cultured in LBS broth
(BBL, Becton Dickinson) without acetic acid and pH ad-
justed to 7 with 5M NaOH (mLBS7) to optimize LAB20
growth, and incubated at 37°C in anaerobic conditions.
Freeze-dried LAB20 cells were prepared as described
previously [24]. The viability of freeze-dried LAB20 is
8% after freeze-drying protocol and the recovery of
freeze-dried LAB20 takes more than 8 hours. L. rhamno-
sus GG was cultured in MRS (Becton Dickinson) broth
under static conditions at 37°C and E. coli TOP10 was
cultured in Luria-Bertani broth (Becton Dickinson) at
37°C.
HT-29 cell and Caco-2 cell cultures
The human intestinal cell lines HT-29 and Caco-2 were
obtained from DSMZ and were grown at 37°C in a 95%
air–5% CO2 atmosphere. HT-29 cells were grown in
McCoy 5A medium (Lonza) supplemented with 10%
heat-inactivated (56°C, 30 min) fetal calf serum (FCS,
Integro B.V.) and 100 U/ml penicillin-streptomycin
(Lonza). Caco-2 cells were grown in RPMI 1640 medium
(Sigma-Aldrich) supplemented with 2 mM L-glutamine
(Lonza), 20% FCS, 100 U/ml penicillin-streptomycin, 15
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(Lonza).
Isolation of human and canine intestinal mucus
Human colonic mucus was collected from a healthy
piece of tissue obtained from patients with colorectal
cancer, by following the previous description [56]. The
use of resected human intestinal tissue for the adhesion
studies was approved by the ethical committee of the
Hospital District of Southwest Finland and the patients
donating their samples for research purposes signed a
written informed consent. Briefly, the mucus was col-
lected into HEPES-Hanks buffer (10 mM HEPES, pH
7.4) by gently scraping with a rubber spatula from
washed resected material (PBS containing 0.01% gelatin),
and stored at −20°C until use. Canine intestinal mucus
was isolated from intestinal mucosa samples taken by
necropsy from the duodenum, jejunum, ileum, cecum,
and colon of six healthy dogs being euthanized after fi-
nalizing an unrelated experimental study. The study
protocol was approved by the Finnish National Animal
Experiment Board (License number ESAVI-2010-04178
Ym-23, PH 1465A). Fresh mucosa was isolated from the
intestinal wall with the back side of a scalpel after thor-
ough cleaning of the surface with cold saline. All sam-
ples were immediately frozen in liquid nitrogen and
stored at −80°C until being melted at room temperature
for further processing. For the adhesion tests the sam-
ples were carefully centrifuged and the mucus and epi-
thelial cells were separated.
Bacterial adhesion to mucus and cell lines
For the adhesion test, mucus samples (50 μg in PBS)
were immobilized passively on Maxisorp microtiter wells
by overnight incubation at 4°C [56]. The wells contain-
ing immobilized mucus were washed twice with PBS
and incubated with blocking buffer (0.5% [w/v] BSA in
PBS) for one hour at room temperature. The Caco-2
and HT-29 cell lines were cultivated on 96-well tissue
culture plate (10,000 cells/well; Nunc) for 3, 8 and 21
days. The cells were washed twice with culture medium
before the adhesion assay. LAB20 was metabolically
radiolabeled by cultivating bacteria with 10 μl/ml [5′-3H]
thymidine (17.0 Ci/mmol; Perkin Elmer). The adhe-
sion assay was performed as described previously by
Kainulainen et al. (2013) [57]. Briefly, after cultivation,
bacteria were collected by centrifugation and washed with
McCoy 5A (adhesion to HT-29) or RPMI (adhesion to
Caco-2) without supplements, or PBS (adhesion to
mucus). The optical density was adjusted (OD600nm =
0.25) to the same culture medium or buffer used for wash-
ing. Bacteria (100 μl) were incubated on mucus at 37°C or
on the IECs in a CO2 incubator at 37°C for one hour, and
the non-adherent bacteria were removed by washing thewells three times with PBS. Bacteria bound to cells or
mucus were lysed with 1% SDS–0.1 M NaOH by incubat-
ing at 60°C for one hour. The radioactivity of the suspen-
sion was measured by liquid scintillation. Four to five
parallel wells (i.e. technical replicates) were used in each
experiment, and all experiments were repeated two to four
times. The percent bacterial adhesion was determined by
calculating the ratio between the radioactivity of the ad-
herent bacteria and that of the added bacteria.
Bacterial adhesion to canine IECs
Canine IECs were isolated from canine mucosa samples
by separating the cells from mucus by centrifugation.
The IECs from duodenum, jejunum, ileum, cecum, and
colon were mounted on glass slides and fixed with 4%
(w/v) paraformaldehyde (Sigma-Aldrich) in PBS (pH 7.4)
for overnight at 4°C. For the adhesion assay, a 1.5-ml
volume of LAB20 cells from two-night culture were col-
lected by centrifugation and washed twice with PBS,
then stained with 2.5 ml of 75 μg/ml of fluorescein iso-
thiocyanate (FITC; Sigma-Aldrich) in PBS (pH 8.2).
After one hour incubation at room temperature in dark
bacterial cells were washed with 0.01% Tween20-PBS
(pH 7.4), and the optical density was adjusted to
OD600nm = 0.25 with the same buffer used for washing.
The FITC-labelled bacteria were incubated with canine
IECs for one hour at room temperature in a moisture
chamber to allow bacteria to bind. The slides were then
washed in 50 ml PBS for three times, and epithelial cells
were stained with 10 μM 4,6'-diamidino-2-phenylindole
(DAPI; Molecular Probes), which binds to nucleic acids.
The adherent bacteria were examined with an epifluor-
escence microscopy (Leica DM 4000B) and images were
digitally recorded using CellP^ imaging software for life
sciences microscopy (Soft Imaging System GmbH). The
assay was carried out twice with duplicate samples, and
the figures are representative microscopic images of bac-
terial adherence.
Induction of IL-8 release from HT-29 by LPS and the at-
tenuation assay
LAB20 cells were harvested from 36–40 hours culture
by centrifugation and freeze-dried LAB20 cells were pre-
pared as described previously [24]. Cells were washed
once with McCoy 5A medium with FCS. The optical
density of bacterial suspensions was adjusted to 0.25 at
600 nm (OD 600), respectively. A 100 μl volume of each
bacterial cell suspension was added to the wells contain-
ing 8-days-old HT-29 cells and incubated at 37°C for
one hour in a 95% air–5% CO2 atmosphere. The control
wells contained only McCoy 5A medium with FCS.
Afterwards, the medium and bacterial suspension were
removed from wells, and 200 μl of E. coli LPS-containing
(0.1 ng/ml or 1 ng/ml) medium were added. The HT-29
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concentration of the medium was measured by ELISA
(Human IL-8 BD OptEIA™ Kit, BD).
Transepithelial electric resistance
The effect of LAB20 on epithelial cell integrity was stud-
ied as previously described by Myllyluoma et al. [58]
with minor modifications. Briefly, LAB20 and E. coli
cells were harvested after cultivation by centrifugation
and washed once with RPMI containing the supple-
ments. The optical density was adjusted to OD600nm =
0.25 with the same RPMI medium. Caco-2 cells (50 000
cells/well) were cultured for eight days on cell culture
inserts (Millipore) with a 3-μm pore size inserted in the
wells of 24-well culture plate. The adjusted bacterial sus-
pension (400 μl) was added on the apical side of the in-
sert and the cultures were incubated at 37°C under a 5%
CO2 atmosphere for 72 h. Transepithelial electrical re-
sistance (TER) across the monolayers was measured by
using Millicell ERS-2 TER meter (Millipore) at 24, 48
and 72 h of incubation. Measurements are expressed as
Ω/cm2 after subtracting the baseline mean resistance of
the same inserts i.e. the resistance at time point 0.
Statistical analysis
A pairwise Student’s t test was used to determine the
significant difference (P < 0.05). Results are shown as
means ± standard deviations for technical replicates from
representative experiments.
Additional file
Additional file 1: Construction of derivate strain SAA658 and
comparison of WT-LAB20 and SAA658 in the IL-8 production assay.
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